IDiyas

For the Inventor, By the Inventor

Haifa, Israel

Ilan Beer

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 83(Granted Patents)


Company Filing History:

goldMedal6 out of 164,108 
 
International Business Machines Corporation
 patents
silverMedal2 out of 944 
 
Technion Research & Development Foundation Limited
 patents
bronzeMedal1 out of 4 
 
Adicet Therapeutics, Inc.
 patents
4. 2 out of 832,680 
Other
 patents

Years Active: 2001-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):
1. 12252547 - Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same (2025-03-18),
2. 11485785 - Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereof (2022-11-01),
3. 11001642 - Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same (2021-05-11),
4. 8949766 - Detecting corresponding paths in combinationally equivalent circuit designs (2015-02-03),
5. 8741581 - Markers for cancer detection (2014-06-03),
6. 7188061 - Simulation monitors based on temporal formulas (2007-03-06),
7. 7146605 - Automatic abstraction of software source (2006-12-05),
8. 6867283 - Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells (2005-03-15),
9. 6715107 - Method and system for reducing the computation tree to include only model behaviors defined succinctly by a user via regular expressions as being of interest (2004-03-30),
10. 6691078 - Target design model behavior explorer (2004-02-10),
11. 6192505 - Method and system for reducing state space variables prior to symbolic model checking (2001-02-20),

Title: Innovations of Ilan Beer

Introduction

Ilan Beer is a prominent inventor based in Haifa, Israel, known for his significant contributions to the field of biotechnology. With a total of 11 patents to his name, he has made remarkable advancements in the development of affinity binding entities and antibodies for therapeutic applications.

Latest Patents

Ilan Beer's latest patents include innovative compositions that comprise a TCR-like antibody binding domain with high affinity and fine specificity. These compositions are designed to bind to specific cells, such as HLA-A2/WT1+, HLA-A2/MAGE-A4, HLA-A2/MAGE-A9, HLA-A2/PAP, or HLA-A2/TyrD+ cells, making them valuable for diagnostics and therapy. Additionally, he has developed antibodies capable of binding HLA-A2/Tyrosinase (TyrD) in an HLA-restricted manner, specifically targeting HLA-A2/TyrD369-377. These antibodies are intended for use in cancer treatment, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Ilan Beer has worked with notable organizations, including IBM and the Technion Research & Development Foundation Limited. His experience in these esteemed institutions has contributed to his expertise and innovative approach in the field of biotechnology.

Collaborations

Ilan Beer has collaborated with several professionals in his field, including Mira Peled Kamar and Galit Denkberg. These partnerships have likely enhanced his research and development efforts, leading to groundbreaking innovations.

Conclusion

Ilan Beer is a distinguished inventor whose work in biotechnology has led to significant advancements in cancer diagnostics and therapy. His innovative patents and collaborations reflect his dedication to improving medical treatments and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…